NCT06121544View on ClinicalTrials.gov

The Swedish BioFINDER - Preclinical AD Study

RecruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Alzheimer DiseaseMild Cognitive ImpairmentMild Dementia
Interventions
DIAGNOSTIC_TEST

Plasma tau

Plasma levels of different p-tau and np-tau species

DIAGNOSTIC_TEST

Plasma Ab42/Ab40

Plasma levels of Ab42/Ab40 ratio

DIAGNOSTIC_TEST

Flutemetamol F18 Injection

Positron emission tomography (PET) imaging of amyloid-β plaques

DIAGNOSTIC_TEST

[18F]-RO6958948 Injection

PET imaging of Tau aggregates

DIAGNOSTIC_TEST

Magnetic resonance imaging (MRI)

Different MRI sequences relevant for brain imaging

Trial Locations (1)

Unknown

RECRUITING

Skåne University Hospital, Malmo

All Listed Sponsors
collaborator

Lund University

OTHER

lead

Skane University Hospital

OTHER